Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aldeyra Therapeutics

4.81
-0.1800-3.61%
Post-market: 4.910.1000+2.08%17:19 EDT
Volume:1.51M
Turnover:7.13M
Market Cap:288.10M
PE:-4.97
High:4.92
Open:4.90
Low:4.23
Close:4.99
Loading ...

Aldeyra Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
29 Apr

Aldeyra Therapeutics Appoints Chip Clark to Board

TIPRANKS
·
18 Apr

Aldeyra options imply 12.1% move in share price post-earnings

TIPRANKS
·
15 Apr

Aldeyra options imply 17.5% move in share price post-earnings

TIPRANKS
·
08 Apr

Aldeyra Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
07 Apr

Aldeyra price target lowered to $9 from $11 at BTIG

TIPRANKS
·
07 Apr

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): When Will It Breakeven?

Simply Wall St.
·
07 Apr

Aldeyra Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Apr

Aldeyra Therapeutics Receives FDA Complete Response Letter

TIPRANKS
·
04 Apr

Aldeyra options imply 35.3% move in share price post-earnings

TIPRANKS
·
04 Apr

Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall

Benzinga
·
03 Apr

Aldeyra Therapeutics Gets US FDA Letter for Resubmission of New Drug Application for Eye Disease Treatment - Shares Slump Pre-Bell

MT Newswires Live
·
03 Apr

Aldeyra down 75% after receiving CRL from FDA for reproxalap

TIPRANKS
·
03 Apr

BUZZ-Aldeyra Therapeutics falls over 70% as FDA declines to approve eye disease drug

Reuters
·
03 Apr

BRIEF-Aldeyra Receives Complete Response Letter From The FDA For The Reproxalap New Drug Application For The Treatment Of Dry Eye Disease

Reuters
·
03 Apr

US FDA declines to approve Aldeyra's eye disease drug

Reuters
·
03 Apr

Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease

Business Wire
·
03 Apr

Aldeyra options imply 29.5% move in share price post-earnings

TIPRANKS
·
28 Mar

High Growth Tech Stocks To Watch In The US March 2025

Simply Wall St.
·
11 Mar

Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference

Business Wire
·
10 Mar